共 203 条
- [1] Zanger UM(2004)Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry Naunyn Schmiedebergs Arch Pharmacol 369 23-37
- [2] Raimundo S(2011)CYP2D6 in the metabolism of opioids for mild to moderate pain Pharmacology 87 274-85
- [3] Eichelbaum M(2017)Prediction of CYP2D6 phenotype from genotype across world populations Genet Med 19 69-76
- [4] Leppert W(2019)Updated clinical pharmacokinetics and pharmacodynamics of Oxycodone Clin Pharmacokinet 58 705-25
- [5] Gaedigk A(2007)Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication Pharmacogenomics J 7 257-65
- [6] Sangkuhl K(1999)Decreased capacity for debrisoquine metabolism among black tanzanians: analyses of the CYP2D6 genotype and phenotype Pharmacogenetics 9 707-14
- [7] Whirl-Carrillo M(2014)Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update Clin Pharmacol Ther 95 376-82
- [8] Klein T(2016)Pain services and prescription of opioid Drugs in Ghana Ghana Med J 50 62-2
- [9] Leeder JS(2010)Access to pain treatment as a human right BMC Med 8 8-20
- [10] Kinnunen M(2008)Opioid Complications and side effects Pain Physician 11 105-52